Skip to menu Skip to content Skip to footer

2024

Journal Article

Utilizing murine dendritic cell line DC2.4 to evaluate the immunogenicity of subunit vaccines in vitro

Lu, Lantian, Kong, Wei Yang, Zhang, Jiahui, Firdaus, Farrhana, Wells, James W., Stephenson, Rachel J., Toth, Istvan, Skwarczynski, Mariusz and Cruz, Jazmina L. Gonzalez (2024). Utilizing murine dendritic cell line DC2.4 to evaluate the immunogenicity of subunit vaccines in vitro. Frontiers in Immunology, 15 ARTN 1298721, 1-13. doi: 10.3389/fimmu.2024.1298721

Utilizing murine dendritic cell line DC2.4 to evaluate the immunogenicity of subunit vaccines in vitro

2024

Journal Article

Arginase-induced cell death pathways and metabolic changes in cancer cells are not altered by insulin

Chew, Hui Yi, Cvetkovic, Goran, Tepic, Slobodan and Wells, James W. (2024). Arginase-induced cell death pathways and metabolic changes in cancer cells are not altered by insulin. Scientific Reports, 14 (1) 4112. doi: 10.1038/s41598-024-54520-z

Arginase-induced cell death pathways and metabolic changes in cancer cells are not altered by insulin

2024

Journal Article

Predicting tacrolimus concentrations in the skin of adult kidney transplant recipients: a feasibility study

Sartain, Felicity, Viecelli, Andrea K., Veitch, Margaret, Franklin, Michael E., Dymock, Brian W., Wells, James W. and Campbell, Scott B. (2024). Predicting tacrolimus concentrations in the skin of adult kidney transplant recipients: a feasibility study. Transplant International, 37 12019. doi: 10.3389/ti.2024.12019

Predicting tacrolimus concentrations in the skin of adult kidney transplant recipients: a feasibility study

2024

Journal Article

Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas

Zeng, Zhen, Ngo, Hung Long, Proctor, Martina, Rizos, Helen, Dolcetti, Riccardo, Cruz, Jazmina Gonzalez, Wells, James W. and Gabrielli, Brian (2024). Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas. Pigment Cell and Melanoma Research, 37 (1), 45-50. doi: 10.1111/pcmr.13120

Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas

2024

Journal Article

Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity

Wright, Quentin G, Sinha, Debottam, Wells, James W, Frazer, Ian H, Gonzalez Cruz, Jazmina L and Leggatt, Graham Robert (2024). Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity. Journal for ImmunoTherapy of Cancer, 12 (1) e007960, e007960. doi: 10.1136/jitc-2023-007960

Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity

2023

Journal Article

Local blockade of tacrolimus promotes T-cell-mediated tumor regression in systemically immunosuppressed hosts

Veitch, Margaret, Beaumont, Kimberly, Pouwer, Rebecca, Chew, Hui Yi, Frazer, Ian H., Soyer, H. Peter, Campbell, Scott, Dymock, Brian W., Harvey, Andrew, Cock, Terrie-Anne and Wells, James W. (2023). Local blockade of tacrolimus promotes T-cell-mediated tumor regression in systemically immunosuppressed hosts. Journal for ImmunoTherapy of Cancer, 11 (9) e006783, 1-15. doi: 10.1136/jitc-2023-006783

Local blockade of tacrolimus promotes T-cell-mediated tumor regression in systemically immunosuppressed hosts

2023

Journal Article

Mono-phosphorylation at Ser4 of barrier-to-autointegration factor (Banf1) significantly reduces its DNA binding capability by inducing critical changes in its local conformation and DNA binding surface

Tang, Ming, Suraweera, Amila, Nie, Xuqiang, Li, Zilin, Lai, Pinglin, Wells, James W., O’Byrne, Kenneth J., Woods, Robert J, Bolderson, Emma and Richard, Derek J (2023). Mono-phosphorylation at Ser4 of barrier-to-autointegration factor (Banf1) significantly reduces its DNA binding capability by inducing critical changes in its local conformation and DNA binding surface. Physical Chemistry Chemical Physics, 25 (36), 24657-24677. doi: 10.1039/d3cp02302h

Mono-phosphorylation at Ser4 of barrier-to-autointegration factor (Banf1) significantly reduces its DNA binding capability by inducing critical changes in its local conformation and DNA binding surface

2023

Journal Article

Enhanced hydrophobicity of CeO2 thin films: role of the morphology, adsorbed species and crystallography

Mamedov, D., Asland, A. C., Cooil, S. P., Rost, H. I., Bakkelund, J., Allaniyazov, A., Wells, J. W. and Karazhanov, S. (2023). Enhanced hydrophobicity of CeO2 thin films: role of the morphology, adsorbed species and crystallography. Materials Today Communications, 35 106323, 1-8. doi: 10.1016/j.mtcomm.2023.106323

Enhanced hydrophobicity of CeO2 thin films: role of the morphology, adsorbed species and crystallography

2023

Journal Article

Liposomal formulations of a polyleucine–antigen conjugate as therapeutic vaccines against cervical cancer

Firdaus, Farrhana Z., Bartlett, Stacey, Hussein, Waleed M., Lu, Lantian, Wright, Quentin, Huang, Wenbin, Nahar, Ummey J., Yang, Jieru, Khongkow, Mattaka, Veitch, Margaret, Koirala, Prashamsa, Ruktanonchai, Uracha R., Monteiro, Michael J., Gonzalez Cruz, Jazmina L., Stephenson, Rachel J., Wells, James W., Toth, Istvan and Skwarczynski, Mariusz (2023). Liposomal formulations of a polyleucine–antigen conjugate as therapeutic vaccines against cervical cancer. Pharmaceutics, 15 (2) 602, 1-15. doi: 10.3390/pharmaceutics15020602

Liposomal formulations of a polyleucine–antigen conjugate as therapeutic vaccines against cervical cancer

2022

Journal Article

Cytokine/Chemokine assessment as a complementary diagnostic tool for inflammatory skin diseases

Liu, Timothy J., Lin, Lynlee L., McMeniman, Erin, Wu, Jason, Kao, Yung-Ching, Kumari, Snehlata, Boyle, Glen M., Wells, James W., Soyer, H. Peter and Gonzalez-Cruz, Jazmina L. (2022). Cytokine/Chemokine assessment as a complementary diagnostic tool for inflammatory skin diseases. Frontiers in Immunology, 13 1028435, 1-8. doi: 10.3389/fimmu.2022.1028435

Cytokine/Chemokine assessment as a complementary diagnostic tool for inflammatory skin diseases

2022

Journal Article

Assessment of patient-to-patient and intra-individual human abdominal skin immune cell variability

Veitch, Margaret, Layt, Craig, Raymond, Emma, Croaker, Andrew and Wells, James (2022). Assessment of patient-to-patient and intra-individual human abdominal skin immune cell variability. Archives of Medical Science, 18 (6), 1683-1688. doi: 10.5114/aoms/155183

Assessment of patient-to-patient and intra-individual human abdominal skin immune cell variability

2022

Journal Article

Prevalence of AAV2.5 neutralizing antibodies in synovial fluid and serum of patients with osteoarthritis

Abdul, Temilola Y., Hawse, Gresin P., Smith, Jay, Sellon, Jacob L., Abdel, Matthew P., Wells, James W., Coenen, Michael J., Evans, Christopher H. and De La Vega, Rodolfo E. (2022). Prevalence of AAV2.5 neutralizing antibodies in synovial fluid and serum of patients with osteoarthritis. Gene Therapy, 30 (7-8), 1-5. doi: 10.1038/s41434-022-00326-5

Prevalence of AAV2.5 neutralizing antibodies in synovial fluid and serum of patients with osteoarthritis

2021

Other Outputs

Compound for prevention or treatment of a skin cancer or skin precancer

Wells, James, Dymock, Brian William, Harvey, Andrew, Cock, Terrie-Anne, Pouwer, Rebecca and Beaumont, Kimberley (2021). Compound for prevention or treatment of a skin cancer or skin precancer. WO2021248189.

Compound for prevention or treatment of a skin cancer or skin precancer

2021

Journal Article

Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial

Depelsenaire, Alexandra C. I., Witham, Katey, Veitch, Margaret, Wells, James W., Anderson, Christopher D., Lickliter, Jason D., Rockman, Steve, Bodle, Jesse, Treasure, Peter, Hickling, Julian, Fernando, Germain J. P. and Forster, Angus H. (2021). Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial. PLoS One, 16 (7) e0255282, e0255282. doi: 10.1371/journal.pone.0255282

Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial

2021

Journal Article

Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression

Proctor, Martina, Gonzalez Cruz, Jazmina L., Daignault-Mill, Sheena M., Veitch, Margaret, Zeng, Bijun, Ehmann, Anna, Sabdia, Muhammed, Snell, Cameron, Keane, Colm, Dolcetti, Riccardo, Haass, Nikolas K., Wells, James W. and Gabrielli, Brian (2021). Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression. Cancers, 13 (15) 3733, 1-19. doi: 10.3390/cancers13153733

Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression

2021

Journal Article

PD-1 and beyond to activate T cells in cutaneous squamous cell cancers: the case for 4-1BB and VISTA antibodies in combination therapy

Wright, Quentin, Gonzalez Cruz, Jazmina L., Wells, James W. and Leggatt, Graham R. (2021). PD-1 and beyond to activate T cells in cutaneous squamous cell cancers: the case for 4-1BB and VISTA antibodies in combination therapy. Cancers, 13 (13) 3310, 3310. doi: 10.3390/cancers13133310

PD-1 and beyond to activate T cells in cutaneous squamous cell cancers: the case for 4-1BB and VISTA antibodies in combination therapy

2021

Journal Article

Evolution of cancer vaccines—challenges, achievements and future directions

Tay, Ban Qi, Wright, Quentin, Ladwa, Rahul, Perry, Christopher, Leggatt, Graham, Simpson, Fiona, Wells, James W., Panizza, Benedict J., Frazer, Ian H. and Cruz, Jazmina L. G. (2021). Evolution of cancer vaccines—challenges, achievements and future directions. Vaccines, 9 (5) 535, 535. doi: 10.3390/vaccines9050535

Evolution of cancer vaccines—challenges, achievements and future directions

2021

Journal Article

IFN-γ critically enables the intratumoural infiltration of CXCR3+ CD8+ T cells to drive squamous cell carcinoma regression

Zeng, Zhen, Veitch, Margaret, Kelly, Gabrielle A., Tuong, Zewen K., Cruz, Jazmina G., Frazer, Ian H. and Wells, James W. (2021). IFN-γ critically enables the intratumoural infiltration of CXCR3+ CD8+ T cells to drive squamous cell carcinoma regression. Cancers, 13 (9) 2131, 2131. doi: 10.3390/cancers13092131

IFN-γ critically enables the intratumoural infiltration of CXCR3+ CD8+ T cells to drive squamous cell carcinoma regression

2021

Journal Article

Healing of sub-critical femoral osteotomies in mice is unaffected by tacrolimus and deletion of recombination activating gene 1

Liu, T-Y, Bartnikowski, M., Wu, A. C., Veitch, M., Sokolowski, K. A., Millard, S. M., Pettit, A. R., Glatt, V., Evans, C. H. and Wells, J. W. (2021). Healing of sub-critical femoral osteotomies in mice is unaffected by tacrolimus and deletion of recombination activating gene 1. European Cells and Materials, 41, 345-354. doi: 10.22203/eCM.v041a22

Healing of sub-critical femoral osteotomies in mice is unaffected by tacrolimus and deletion of recombination activating gene 1

2021

Journal Article

Investigating T cell immunity in cancer: achievements and prospects

Zeng, Zhen, Chew, Hui Yi, Cruz, Jazmina G., Leggatt, Graham R. and Wells, James W. (2021). Investigating T cell immunity in cancer: achievements and prospects. International Journal of Molecular Sciences, 22 (6) 2907, 1-17. doi: 10.3390/ijms22062907

Investigating T cell immunity in cancer: achievements and prospects